Myths vs facts: TCF7L2 and blood sugar

TCF7L2 is a transcription factor in the Wnt pathway and the strongest genetic risk factor for type 2 diabetes identified by GWAS. The risk variant (e.g., rs7903146) impairs insulin secretion from beta cells, thereby raising fasting blood glucose over time. However, penetrance is low: most carriers never develop diabetes, and lifestyle factors (diet, exercise, weight) have a much larger impact. Direct-to-consumer tests tend to exaggerate the effect size and often imply a 'diabetes guarantee.' In reality, TCF7L2 explains only a small fraction of individual risk. The evidence is based on large human meta-analyses (GWAS), but clinical predictive power is limited. A genetic test alone is no substitute for blood glucose measurement or medical evaluation. Carriers of the risk variant should focus on a healthy lifestyle without falling into fatalism.